Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Polymorphs of ARRY-380, a selective HER2 inhibitor and pharmaceutical compositions containing them

Polymorphs of ARRY-380, a selective HER2 inhibitor and pharmaceutical compositions containing them

US Patent 10143692 · Granted Dec 4, 2018

Estimated economic value: $21,552,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Solid dispersions and pharmaceutical compositions comprising a substituted indan2025
Sustained delivery formulations of risperidone compound2023
Polymorphs of ARRY-380, a selective HER2 inhibitor and pharmaceutical compositio2023
Polymorphs of ARRY-380, a selective HER2 inhibitor and pharmaceutical compositio2023
Polymorphs of ARRY-380, a selective HER2 inhibitor and pharmaceutical compositio2023
Sustained delivery formulations of risperidone compound2021
1 -((3S,4R)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-2020
Polymorphs of ARRY-380, a selective HER2 inhibitor and pharmaceutical compositio2020
Polymorphs of ARRY-380, a selective HER2 inhibitor and pharmaceutical compositio2020
Polymorphs of ARRY-380, a selective HER2 inhibitor and pharmaceutical compositio2020
Crystalline forms of (R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)me2020
Sustained delivery formulations of risperidone compound2019